CG Oncology CGON Q1 2025 earnings
Reported May 13, 2025 · Before market open
Revenue$52.0KMiss by $66.2K
EPS-$0.45Miss by $0.06
Revenue estimate$118.2K
EPS estimate-$0.39
Next report
Aug 7, 2026 (In 1 week)Revenue estimate$360.8K
EPS estimate-$0.70
Financials
Q1 2025Valuation & ratios
Segments
By product
Versus estimates
Revenue
Q1 2026$1.1MBeat by $630.0KQ4 2025$2.3MBeat by $1.8MQ3 2025$1.7MBeat by $1.6M
Q1 2025$52.0KMiss by $66.2K
Q4 2024$456.0KBeat by $332.1KDiluted EPS
Ask the moment CG Oncology reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did CG Oncology report Q1 2025 earnings?
- CG Oncology (CGON) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were CG Oncology's Q1 2025 revenue and EPS?
- CG Oncology reported revenue of $52.0K and eps of $-0.45 for Q1 2025.
- Did CG Oncology beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $118.2K by $66.2K. EPS missed the consensus estimate of $-0.39 by $0.06.
- How did CG Oncology's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 90.2% from $529.0K a year earlier and eps declined 25.0% from $-0.36.
- Where can I find CG Oncology's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-069831) directly on SEC EDGAR. The filing index links above go to sec.gov.